Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
Health Technology » Pharmaceuticals Major
|JNJ||Johnson & Johnson||0.40%||160.11||0.7%||$1208.66m|
|MRK||Merck & Co., Inc.||0.00%||76.43||0.7%||$966.72m|
|BMY||Bristol-Myers Squibb Co.||0.41%||63.84||1.0%||$725.84m|
|LLY||Eli Lilly & Co.||0.33%||183.13||1.1%||$599.57m|
|RPRX||Royalty Pharma Plc||1.67%||42.12||0.2%||$163.20m|
|ATNF||180 Life Sciences Corp.||-3.06%||10.46||0.0%||$62.67m|
|BHVN||Biohaven Pharmaceutical Holding Co. Ltd.||2.94%||74.92||0.0%||$61.28m|
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.